Floatz logo

Dna Plasmid-Encoding Interleukin-12/Hpv Dna Plasmids Therapeutic Vaccine Medi0457

Recurrent Anal Canal Carcinoma

M.D. Anderson Cancer CentervaccinePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

7 Active assets in the Recurrent Anal Canal Carcinoma cohort.

Asset / SponsorPhaseRating
Carboplatin
ECOG-ACRIN Cancer Research Group
Phase 2B
FLUOROURACILUM
ECOG-ACRIN Cancer Research Group
Phase 2B
Toripalimab
Sun Yat-sen University
Phase 2B
CIS-DIAMMINEDICHLOROPLATINUM II
M.D. Anderson Cancer Center
Phase 2B
Durvalumab
M.D. Anderson Cancer Center
Phase 2CCC

View all 14 →

Same molecule, other indications

Dna Plasmid-Encoding Interleukin-12/Hpv Dna Plasmids Therapeutic Vaccine Medi0457 is also rated in:

metastatic malignant neoplasmDormant
CCC
Indicative ·
53 / 100
View asset →
cervical carcinomaDormant
CCC
Indicative ·
53 / 100
View asset →
human papilloma virus infectionDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →